Skip to main content
. 2015 Jan 28;2015:486832. doi: 10.1155/2015/486832

Table 2.

Preoperative and postoperative 18-month values in the ppAGV and acAGV groups.

ppAGV (n = 18) acAGV (n = 18) P value
ECC, cells/mm2
 Preoperative 2337 ± 311 2334 ± 302 0.98
 Postoperative 2044 ± 303 1904 ± 324 0.25
P value <0.001 <0.001
BCVA, LogMAR
 Preoperative 1.76 ± 0.91 2.10 ± 0.93 0.31
 Postoperative 1.27 ± 0.97 1.64 ± 1.18 0.21
P value 0.070 0.063
IOP, mmHg
 Preoperative 35.9 ± 7.6 39.7 ± 12.7 0.26
 Postoperative 16.5 ± 7.5 17.1 ± 8.6 0.87
P value <0.001 <0.001
Glaucoma medication
 Preoperative 2.9 ± 0.3 2.7 ± 0.6 0.39
 Postoperative 1.5 ± 0.8 1.6 ± 0.8 0.52
P value <0.001 <0.001
Surgical outcome (%)
 Success 16 88.8 14 77.8 0.66
 Failure 2 11.2 4 22.2

ppAGV: pars plana implantation of an Ahmed glaucoma valve (AGV), acAGV: anterior chamber implantation of an AGV, ECC: endothelial cell count, BCVA: best corrected visual acuity, LogMAR: logarithm of the minimal angle of resolution, and IOP: intraocular pressure.